Wake Forest University
Wake Forest University
Winston-Salem, North Carolina, United States22 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Administration of T Lymphocytes for Prevention of Relapse of Lymphomas | Hemic and Lymphatic Diseases, Hodgkins lymphoma, Neoplasms by Histologic Type, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasm | Active, not recruiting | Phase 1 | 2026-10-01 | NCT02663297 | |
| Myocardial Mechanisms in Heart Failure With Preserved Ejection Fraction | cardiovascular disorder, heart disorder, heart failure | Recruiting | Not stated | 2026-09-29 | NCT06517186 | |
| HeartShare: Combining Omics, Deep Phenotyping, and Electronic Health Records for Heart Failure Subtypes and Treatment Targets | cardiovascular disorder, heart disorder, heart failure | Recruiting | Not stated | 2026-09-29 | NCT05873634 | |
| Supporting Families in the ICU | anxiety, anxiety disorder, psychiatric disorder | Not yet recruiting | Not applicable | 2026-08-27 | NCT07228299 | |
| Automated Imaging Differentiation of Parkinsonism | Neurologic Manifestations, Ocular Motility Disorders, Parkinson disease, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, autonomic nervous system disorder, basal ganglia disorder, brain disorder, central nervous system disorder, cranial nerve neuropathy, eye disorder, movement disorder, multiple system atrophy, nervous system disorder, neurodegenerative disease, ophthalmoplegia, palsy, parkinsonian disorder, primary dysautonomia, progressive supranuclear palsy, synucleinopathy, tauopathy | Active, not recruiting | Not stated | 2026-07-31 | NCT05913687 | |
| VictORION-INCLUSION: Evaluating Inclisiran for Cholesterol Managment in Heart Disease | Arterial Occlusive Diseases, Dyslipidemias, Hypercholesterolemia, Lipid Metabolism Disorders, Nutritional and Metabolic Diseases, arteriosclerosis disorder, atherosclerosis, atherosclerotic cardiovascular disease, cardiovascular disorder, hyperlipidemia, metabolic disease, vascular disorder | Active, not recruiting | Phase 4 | 2026-07-29 | NCT06249165 | |
| FiberLocker® System Augmentation of Rotator Cuff Repairs | Rotator Cuff Injuries, Rotator Cuff Tears, Rupture, Shoulder Injuries, Tendon Injuries, injury | Recruiting | Not applicable | 2026-07-08 | NCT06918041 | |
| A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs) | Bone Marrow Failure Disorders, Chronic Disease, Disease Attributes, Hemic and Lymphatic Diseases, Hodgkins lymphoma, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Myeloproliferative Disorders, Neoplasms by Histologic Type, Neoplasms by Site, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Precursor Cell Lymphoblastic Leukemia-Lymphoma, acute lymphoblastic leukemia, acute myeloid leukemia, anemia, aplastic anemia, autoimmune disease, bone marrow disorder, chronic myeloid leukemia, disease, hematologic disorder, hematopoietic and lymphoid system neoplasm, immune system disorder, immunoproliferative disorder, inborn errors of metabolism, leukemia, lymphatic system disorder, lymphoid leukemia, lymphoma, lymphoproliferative syndrome, myeloid leukemia, neoplasm, non-Hodgkin lymphoma | Recruiting | Not stated | 2026-07-06 | NCT01351545 | |
| Clinical Procedures to Support Research in ALS | Nutritional and Metabolic Diseases, TDP-43 proteinopathy, amyotrophic lateral sclerosis, central nervous system disorder, lateral sclerosis, metabolic disease, motor neuron disorder, nervous system disorder, neurodegenerative disease, neuromuscular disease, progressive muscular atrophy, proteostasis deficiencies, spinal cord disorder, spinal muscular atrophy | Recruiting | Not stated | 2026-06-15 | NCT03489278 | |
| Phenotype, Genotype & Biomarkers in ALS and Related Disorders | Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Frontotemporal Lobar Degeneration, Nutritional and Metabolic Diseases, TDP-43 proteinopathy, amyotrophic lateral sclerosis, brain disorder, central nervous system disorder, central nervous system malformation, cognitive disorder, dementia, frontotemporal dementia, hereditary disease, hereditary motor and sensory neuropathy, hereditary spastic paraplegia, inherited neurodegenerative disorder, lateral sclerosis, metabolic disease, motor neuron disorder, nervous system disorder, neurodegenerative disease, neuromuscular disease, peripheral nervous system disorder, polyneuropathy, progressive muscular atrophy, proteostasis deficiencies, psychiatric disorder, spinal cord disorder, spinal muscular atrophy | Active, not recruiting | Not stated | 2026-06-15 | NCT02327845 | |
| JOURNEY™ II CR Total Knee System | arthritic joint disease, arthropathy, musculoskeletal system disorder, osteoarthritis, osteoarthritis, knee, rheumatic disorder | Active, not recruiting | Not stated | 2026-06-12 | NCT02440672 | |
| Open Versus Arthroscopic Stabilization of Shoulder Instability With Subcritical Bone Loss: The OASIS Trial | Joint Dislocations, Shoulder Dislocation, Shoulder Injuries, arthropathy, injury, musculoskeletal system disorder | Recruiting | Not stated | 2026-06-08 | NCT04809064 | |
| Study of Individuals Affected With Hypoplasminogenemia | hypoplasminogenemia | Recruiting | Not stated | 2026-06-04 | NCT03797495 | |
| Use of CereGate Therapy for Freezing of Gait in PD | Gait Disorders, Neurologic, Mobility Limitation, Motor Disorders, Neurologic Manifestations, Parkinson disease, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, basal ganglia disorder, brain disorder, central nervous system disorder, movement disorder, nervous system disorder, neurodegenerative disease, parkinsonian disorder, psychiatric disorder, synucleinopathy | Recruiting | Not applicable | 2026-05-28 | NCT05292794 | |
| Chronic Subdural Hematoma Treatment With Embolization Versus Surgery Study | Chronic Disease, Craniocerebral Trauma, Disease Attributes, Hematoma, Hematoma, Subdural, Hematoma, Subdural, Chronic, Hemorrhage, Intracranial Hemorrhage, Traumatic, Intracranial Hemorrhages, Pathologic Processes, Pathological Conditions, Signs and Symptoms, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, injury, nervous system disorder, nervous system injury, vascular disorder | Recruiting | Not applicable | 2026-05-22 | NCT06347796 | |
| DISCOVERY of Risk Factors for Type 2 Diabetes in Youth | Nutritional and Metabolic Diseases, diabetes mellitus, endocrine system disorder, glucose metabolism disease, metabolic disease, type 2 diabetes mellitus | Recruiting | Not stated | 2026-05-07 | NCT06525259 | |
| mPATH-Cloud for Colorectal Cancer Screening | Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, colonic disorder, colorectal cancer, colorectal neoplasm, digestive system disorder, digestive system neoplasm, intestinal disorder, neoplasm, rectal disorder | Active, not recruiting | Not applicable | 2026-04-30 | NCT06441487 | |
| Local Bisphosphonate Effect on Recurrence Rate in Extremity Giant Cell Tumor of Bone | Neoplasms by Histologic Type, Neoplasms, Bone Tissue, Neoplasms, Connective and Soft Tissue, bone giant cell tumor, connective tissue neoplasm, giant cell tumor, neoplasm | Recruiting | Phase 3 | 2026-04-22 | NCT03295981 | |
| Randomized Trial of Lenalidomide, Bortezomib, Dexamethasone vs High-Dose Treatment With SCT in MM Patients up to Age 65 | Blood Protein Disorders, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, cardiovascular disorder, hematologic disorder, hemorrhagic disease, immune system disorder, immunoproliferative disorder, lymphoproliferative syndrome, monoclonal gammopathy, neoplasm, plasma cell neoplasm, vascular disorder, vascular hemostatic disease | Active, not recruiting | Phase 3 | 2026-01-22 | NCT01208662 | |
| Low-Dose Tamoxifen Citrate in Reducing Breast Cancer Risk in Radiation-Induced Cancer Survivors | Neoplasms by Site, Skin and Connective Tissue Diseases, breast cancer, breast disorder, breast neoplasm, neoplasm, skin disorder | Active, not recruiting | Phase 2 | 2026-01-05 | NCT01196936 | |
| Biomarker Development for Muscular Dystrophies | Becker muscular dystrophy, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Duchenne muscular dystrophy, Muscular Disorders, Atrophic, X-linked disease, facioscapulohumeral muscular dystrophy, hereditary disease, inherited neurodegenerative disorder, muscle tissue disorder, muscular dystrophy, musculoskeletal system disorder, myotonic dystrophy, myotonic syndrome, nervous system disorder, neurodegenerative disease, neuromuscular disease | Recruiting | Not stated | 2025-11-24 | NCT05019625 | |
| Study of COPD Subgroups and Biomarkers | Chronic Disease, Disease Attributes, Infections, Pathologic Processes, Pathological Conditions, Signs and Symptoms, bronchial disorder, bronchitis, chronic bronchitis, chronic obstructive pulmonary disease, lung disorder, obstructive lung disease, pulmonary emphysema, respiratory system disorder, respiratory tract infectious disorder | Active, not recruiting | Not stated | 2025-11-13 | NCT01969344 |